학술논문
PB2102: PHASE 2 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLAMOTAMAB COMBINED WITH TAFASITAMAB (TAFA) + LENALIDOMIDE (LEN) VS TAFA+LEN IN RELAPSED OR REFRACTORY DLBCL
Document Type
article
Author
Source
HemaSphere, Vol 6, Pp 1973-1974 (2022)
Subject
Language
English
ISSN
2572-9241